Estimating the clinical cost of drug development for orphan versus non-orphan drugs

BACKGROUND: High orphan drug prices have gained the attention of payers and policy makers. These prices may reflect the need to recoup the cost of drug development from a small patient pool. However, estimates of the cost of orphan drug development are sparse. METHODS: Using publicly available data,...

Descripción completa

Detalles Bibliográficos
Autores principales: Jayasundara, Kavisha, Hollis, Aidan, Krahn, Murray, Mamdani, Muhammad, Hoch, Jeffrey S., Grootendorst, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327525/
https://www.ncbi.nlm.nih.gov/pubmed/30630499
http://dx.doi.org/10.1186/s13023-018-0990-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327525/
https://www.ncbi.nlm.nih.gov/pubmed/30630499
http://dx.doi.org/10.1186/s13023-018-0990-4

Ejemplares similares